Literature DB >> 27585367

A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.

Rupesh Agrawal1, Praveen Kumar Balne2, Anuradha Veerappan3, Veonice Bijin Au4, Bernett Lee4, Eileen Loo2, Arkasubhra Ghosh5, Louis Tong6, Stephen C Teoh7, John Connolly4, Petrina Tan8.   

Abstract

PURPOSE: To investigate the tear cytokine profile in HIV patients with dry eye disease (DED) and study the association between the severity of ocular inflammatory complications and tear cytokines levels. We postulate that HIV-mediated inflammation may be the underlying pathogenic mechanism for HIV-associated DED.
METHODS: The current prospective case-control study compared tear film cytokine profiles in DED patients with HIV infection (n=34) and age/gender-matched DED patients without HIV infection [controls (n=32)]. Participants were recruited from tertiary referral eye care centre and communicable disease clinics, Singapore. Ocular surface health was documented using tear film, Schirmer's test, corneal staining, and conjunctival injection measurements. Tear samples were collected using Schirmer's strips and analysed for the levels of 41 cytokines using Luminex bead assay. Logistic regression models were performed to determine correlation and significance.
RESULTS: Among the 41 cytokines analysed, statistically significant differences were observed in the mean values of epithelial growth factor (EGF), growth related oncogene (GRO) and interferon gamma-induced protein 10 (IP-10). EGF and IP-10 levels were higher and GRO levels were lower in the tears of DED patients with HIV infection compared to DED patients without HIV infection. No significant association was found between varying levels of ocular surface parameters and cytokine concentrations in HIV patients with DED (p>0.05).
CONCLUSIONS: EGF and IP-10 were significantly elevated and GRO levels were lower in the tear profile of HIV patients with DED compared to immunocompetent patients with DED. This study suggests a novel cytokine driven paradigm for ocular inflammatory complications of HIV infection. Additional studies in large organised cohorts can validate the results.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Dry eye; HIV; Inflammation; Luminex bead assay; Ocular surface; Tears

Mesh:

Substances:

Year:  2016        PMID: 27585367     DOI: 10.1016/j.cyto.2016.08.026

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles.

Authors:  Praveen Kumar Balne; Veonice Bijin Au; Louis Tong; Arkasubhra Ghosh; Mukesh Agrawal; John Connolly; Rupesh Agrawal
Journal:  J Vis Exp       Date:  2017-10-13       Impact factor: 1.355

Review 2.  Immune - Goblet cell interaction in the conjunctiva.

Authors:  Jehan Alam; Cintia S de Paiva; Stephen C Pflugfelder
Journal:  Ocul Surf       Date:  2020-01-14       Impact factor: 5.033

3.  Dataset of longitudinal analysis of tear cytokine levels, CD4, CD8 counts and HIV viral load in dry eye patients with HIV infection.

Authors:  Praveen Kumar Balne; Rupesh Agrawal; Veonice Bijin Au; Bernett Lee; Eileen Loo; Louis Tong; Arkasubhra Ghosh; Stephen C Teoh; John Connolly; Petrina Tan
Journal:  Data Brief       Date:  2017-02-03

Review 4.  Role of tear film biomarkers in the diagnosis and management of dry eye disease.

Authors:  Pak Yui Fong; Kendrick Co Shih; Pun Yuet Lam; Tommy Chung Yan Chan; Vishal Jhanji; Louis Tong
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

5.  Dataset of tear film cytokine levels in dry eye disease (DED) patients with and without HIV infection.

Authors:  Praveen Kumar Balne; Rupesh Agrawal; Veonice Bijin Au; Bernett Lee; Eileen Loo; Louis Tong; Arkasubhra Ghosh; Stephen C Teoh; John Connolly; Petrina Tan
Journal:  Data Brief       Date:  2016-11-26

6.  Tear Luminex Analysis in Dry Eye Patients.

Authors:  Hailan Zhao; Qiushi Li; Mingxia Ye; Jie Yu
Journal:  Med Sci Monit       Date:  2018-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.